Your a complete idiot. Research a company before you short, trading just on technicals will get you burned. PSDV will soon bring launches of Iluvien in several large European markets, initiation of phase III trials of FAc for posterior uveitis, and a resubmission of the Iluvien NDA. I will laugh so hard if you wake up tomorrow and this is trading at $5+. I also mostly short stocks, just not PSDV-- which is a buy, buy buy!!